Summary of opinion: Omvoh, 12/12/2024 Positive

Summary of opinion: Jemperli, 12/12/2024 Positive

Summary of opinion: Blincyto, 12/12/2024 Positive

First medicine to treat rare genetic disorder causing cysts and tumours

Summary of opinion: Vocabria, 12/12/2024 Positive

Alofisel withdrawn from the EU market

First treatment recommended for rare progressive lung conditions in children and adolescents

Human medicines European public assessment report (EPAR): Rydapt, midostaurin, Date of authorisation: 18/09/2017, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Relistor, methylnaltrexone bromide, Date of authorisation: 01/07/2008, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Ledaga, chlormethine, Date of authorisation: 03/03/2017, Revision: 10, Status: Authorised